A new era in posterior segment ocular drug delivery: Translation of systemic, cell-targeted, dendrimer-based therapies

RM Kannan, I Pitha, KS Parikh - Advanced Drug Delivery Reviews, 2023 - Elsevier
Vision impairment and loss due to posterior segment ocular disorders, including age-related
macular degeneration and diabetic retinopathy, are a rapidly growing cause of disability …

[HTML][HTML] Advances in PSMA theranostics

TM Jeitner, JW Babich, JM Kelly - Translational Oncology, 2022 - Elsevier
The validation of prostate specific membrane antigen (PSMA) as a molecular target in
metastatic castration-resistant prostate cancer has stimulated the development of multiple …

Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases

M Mistretta, A Farini, Y Torrente, C Villa - Brain, 2023 - academic.oup.com
Neurodegenerative diseases are a major global health burden particularly with the
increasing ageing population. Hereditary predisposition and environmental risk factors …

Polymeric dendrimers as nanocarrier vectors for neurotheranostics

H Li, S Zha, H Li, H Liu, KL Wong, AH All - Small, 2022 - Wiley Online Library
Dendrimers are polymers with well‐defined 3D branched structures that are vastly utilized in
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …

Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders

S Yang, D Datta, E Woo, A Duque, YM Morozov… - Molecular …, 2022 - nature.com
Glutamate carboxypeptidase-II (GCPII) expression in brain is increased by inflammation, eg
by COVID19 infection, where it reduces NAAG stimulation of metabotropic glutamate …

Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders

AFT Arnsten, Y Ishizawa, Z Xie - Molecular Psychiatry, 2023 - nature.com
Neuroinflammatory disorders preferentially impair the higher cognitive and executive
functions of the prefrontal cortex (PFC). This includes such challenging disorders as …

Dendrimers in neurodegenerative diseases

MD Pérez-Carrión, I Posadas - Processes, 2023 - mdpi.com
Neurodegenerative diseases (NDs), such as Parkinson's Disease (PD), Alzheimer's Disease
(AD), Multiple Sclerosis (MS) and amyotrophic lateral sclerosis (ALS), are characterized by …

Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier

M Beygi, F Oroojalian, S Azizi‐Arani… - Advanced Functional …, 2024 - Wiley Online Library
The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed
with tight junctions and adherent junctions that regulates the transport of various materials …

Scientific rationale for the treatment of cognitive deficits from long COVID

A Fesharaki Zadeh, AFT Arnsten, M Wang - Neurology International, 2023 - mdpi.com
Sustained cognitive deficits are a common and debilitating feature of “long COVID”, but
currently there are no FDA-approved treatments. The cognitive functions of the dorsolateral …

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model

C Tallon, BJ Bell, MM Malvankar, P Deme… - Translational …, 2023 - Springer
Abstract Background Cognitive decline in Alzheimer's disease (AD) is associated with
hyperphosphorylated tau (pTau) propagation between neurons along synaptically …